| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From Kaiser Permanente Division of Research (Drs. Whitmer, Sidney, and Selby), Oakland, CA; and Departments of Neurology (Drs. Claiborne Johnston and Yaffe), Epidemiology (Drs. Claiborne Johnston and Yaffe), and Psychiatry (Dr. Yaffe), University of California San Francisco.
Address correspondence and reprint requests to Dr. Rachel Whitmer, 2000 Broadway, Kaiser Permanente Division of Research, Oakland, CA 94612; e-mail: raw{at}dor.kaiser.org
Objective: To evaluate if midlife cardiovascular risk factors are associated with risk of late-life dementia in a large, diverse cohort.
Method: The authors conducted a retrospective cohort study of 8,845 participants of a health maintenance organization who underwent health evaluations from 1964 to 1973 when they were between the ages of 40 and 44. Midlife cardiovascular risk factors included total cholesterol, diabetes, hypertension, and smoking. Diagnoses of dementia were ascertained by medical records from January 1994 to April 2003.
Results: The authors identified 721 participants (8.2%) with dementia. Smoking, hypertension, high cholesterol, and diabetes at midlife were each associated with a 20 to 40% increase in risk of dementia (fully adjusted Cox proportional hazards model: HR 1.24, 95% CI 1.04 to 1.48 for hypertension, HR 1.26, 95% CI 1.08 to 1.47 for smoking, HR 1.42, 95% CI 1.22 to 1.66 for high cholesterol, and HR 1.46, 95% CI 1.19 to 1.79 for diabetes). A composite cardiovascular risk score was created using all four risk factors and was associated with dementia in a dose-dependent fashion. Compared with participants having no risk factors, the risk for dementia increased from 1.27 for having one risk factor to 2.37 for having all four risk factors (fully adjusted model: HR 2.37, 95% CI 1.10 to 5.10).
Conclusion: The presence of multiple cardiovascular risk factors at midlife substantially increases risk of late-life dementia in a dose dependent manner.
Supported by grant 1K12AR47659 from the National Institutes of Health.
Received October 19, 2003. Accepted in final form September 8, 2004.
This article has been cited by other articles:
|
|
 |
|
  R. A. Whitmer, D. R. Gustafson, E. Barrett-Connor, M. N. Haan, E. P. Gunderson, and K. Yaffe Central obesity and increased risk of dementia more than three decades later Neurology, September 30, 2008; 71(14): 1057 - 1064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Coley, S. Andrieu, V. Gardette, S. Gillette-Guyonnet, C. Sanz, B. Vellas, and A. Grand Dementia Prevention: Methodological Explanations for Inconsistent Results Epidemiol. Rev., September 8, 2008; (2008) mxn010v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Beeri, J. Schmeidler, J. M. Silverman, S. Gandy, M. Wysocki, C. M. Hannigan, D. P. Purohit, G. Lesser, H. T. Grossman, and V. Haroutunian Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology Neurology, September 2, 2008; 71(10): 750 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Scazufca, P. R Menezes, R. Araya, V. D Di Rienzo, O. P Almeida, D. Gunnell, and D. A Lawlor Risk factors across the life course and dementia in a Brazilian population: results from the Sao Paulo Ageing & Health Study (SPAH) Int. J. Epidemiol., August 1, 2008; 37(4): 879 - 890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Mielke, Q.-L. Xue, J. Zhou, P. H. M. Chaves, L. P. Fried, and M. C. Carlson Baseline Serum Cholesterol Is Selectively Associated With Motor Speed and Not Rates of Cognitive Decline: The Women's Health and Aging Study II J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2008; 63(6): 619 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Anstey, D. M. Lipnicki, and L.-F. Low Cholesterol as a Risk Factor for Dementia and Cognitive Decline: A Systematic Review of Prospective Studies With Meta-Analysis Am J Geriatr Psychiatry, May 1, 2008; 16(5): 343 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Hajjar, M. Keown, P. Lewis, and A. Almor Angiotensin Converting Enzyme Inhibitors and Cognitive and Functional Decline in Patients with Alzheimer's Disease: An Observational Study American Journal of Alzheimer's Disease and Other Dementias, March 1, 2008; 23(1): 77 - 83. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Knecht, H. Wersching, H. Lohmann, M. Bruchmann, T. Duning, R. Dziewas, K. Berger, and E. B. Ringelstein High-Normal Blood Pressure Is Associated With Poor Cognitive Performance Hypertension, March 1, 2008; 51(3): 663 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Rolandsson, A. Backestrom, S. Eriksson, G. Hallmans, and L.-G. Nilsson Increased Glucose Levels Are Associated With Episodic Memory in Nondiabetic Women Diabetes, February 1, 2008; 57(2): 440 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Simon, H. Chen, M. Schwarzschild, and A. Ascherio Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease Neurology, October 23, 2007; 69(17): 1688 - 1695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. van den Berg, G. J. Biessels, A. J.M de Craen, J. Gussekloo, and R.G.J. Westendorp The metabolic syndrome is associated with decelerated cognitive decline in the oldest old Neurology, September 4, 2007; 69(10): 979 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-J. Chiang, P.-K. Yip, S.-C. Wu, C.-S. Lu, C.-W. Liou, H.-C. Liu, C.-K. Liu, C.-H. Chu, C.-S. Hwang, S.-F. Sung, et al. Midlife Risk Factors for Subtypes of Dementia: A Nested Case-Control Study in Taiwan Am J Geriatr Psychiatry, September 1, 2007; 15(9): 762 - 771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Miyasaka, M. E. Barnes, R. C. Petersen, S. S. Cha, K. R. Bailey, B. J. Gersh, G. Casaclang-Verzosa, W. P. Abhayaratna, J. B. Seward, T. Iwasaka, et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort Eur. Heart J., August 2, 2007; 28(16): 1962 - 1967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Scarmeas Invited Commentary: Lipoproteins and Dementia--Is It the Apolipoprotein A-I? Am. J. Epidemiol., May 1, 2007; 165(9): 993 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Solomon, I. Kareholt, T. Ngandu, B. Winblad, A. Nissinen, J. Tuomilehto, H. Soininen, and M. Kivipelto Serum cholesterol changes after midlife and late-life cognition: Twenty-one-year follow-up study Neurology, March 6, 2007; 68(10): 751 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Staessen, T. Richart, and W. H. Birkenhager Less Atherosclerosis and Lower Blood Pressure for a Meaningful Life Perspective With More Brain Hypertension, March 1, 2007; 49(3): 389 - 400. [Full Text] [PDF]
|
|
|
|
|
|
W. Xu, C. Qiu, B. Winblad, and L. Fratiglioni The Effect of Borderline Diabetes on the Risk of Dementia and Alzheimer's Disease Diabetes, January 1, 2007; 56(1): 211 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Burns and J. O'Brien Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. J Psychopharmacol, November 1, 2006; 20(6): 732 - 755. [Abstract] [PDF]
|
|
|
|
|
|
C. Regan, C. Katona, Z. Walker, J. Hooper, J. Donovan, and G. Livingston Relationship of vascular risk to the progression of Alzheimer disease Neurology, October 24, 2006; 67(8): 1357 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Friedlander, D. C. Norman, M. E. Mahler, K. M. Norman, and J. A. Yagiela Alzheimer's disease: Psychopathology, medical management and dental implications. J Am Dent Assoc, September 1, 2006; 137(9): 1240 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Llorente and V. Urrutia Diabetes, Psychiatric Disorders, and the Metabolic Effects of Antipsychotic Medications Clin. Diabetes, January 1, 2006; 24(1): 18 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Li, J. B. Shofer, W. A. Kukull, E. R. Peskind, D. W. Tsuang, J.C.S. Breitner, W. McCormick, J. D. Bowen, L. Teri, G. D. Schellenberg, et al. Serum cholesterol and risk of Alzheimer disease: A community-based cohort study Neurology, October 11, 2005; 65(7): 1045 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J Goble Obesity in middle age and future risk of dementia: Problem is probably greater for women BMJ, August 20, 2005; 331(7514): 454 - 454. [Full Text]
|
|
|
|
|
|
R. Whitmer, C. P Quesenberry Jr, and K. Yaffe Obesity in middle age and future risk of dementia: Authors' reply BMJ, August 20, 2005; 331(7514): 455 - 455. [Full Text]
|
|
|
|
|
|
R. A Whitmer, E. P Gunderson, E. Barrett-Connor, C. P Quesenberry Jr, and K. Yaffe Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study BMJ, June 11, 2005; 330(7504): 1360. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
